According to this latest study, the 2021 growth of Anti–vascular Endothelial Growth Factor Therapy will have significant change from previous year. By the most conservative estimates of global Anti–vascular Endothelial Growth Factor Therapy market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Anti–vascular Endothelial Growth Factor Therapy market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti–vascular Endothelial Growth Factor Therapy market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Extraction Injection
Precharge Injection
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Macular Degeneration
Nacular Edema
Uveitis
Retinal Vein Occlusion
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Regeneron Pharmaceuticals (Eylea)
Genentech
Kanghong Pharmaceutical
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Anti–vascular Endothelial Growth Factor Therapy Market Size 2016-2026
2.1.2 Anti–vascular Endothelial Growth Factor Therapy Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Anti–vascular Endothelial Growth Factor Therapy Segment by Type
2.2.1 Extraction Injection
2.2.2 Extraction Injection
2.3 Anti–vascular Endothelial Growth Factor Therapy Market Size by Type
2.3.1 Global Anti–vascular Endothelial Growth Factor Therapy Market Size CAGR by Type
2.3.2 Global Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Type (2016-2021)
2.4 Anti–vascular Endothelial Growth Factor Therapy Segment by Application
2.4.1 Macular Degeneration
2.4.2 Nacular Edema
2.4.3 Uveitis
2.4.4 Retinal Vein Occlusion
2.5 Anti–vascular Endothelial Growth Factor Therapy Market Size by Application
2.5.1 Global Anti–vascular Endothelial Growth Factor Therapy Market Size CAGR by Application
2.5.2 Global Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Application (2016-2021)
3 Anti–vascular Endothelial Growth Factor Therapy Market Size by Players
3.1 Anti–vascular Endothelial Growth Factor Therapy Market Size Market Share by Players
3.1.1 Global Anti–vascular Endothelial Growth Factor Therapy Revenue by Players (2019-2021E)
3.1.2 Global Anti–vascular Endothelial Growth Factor Therapy Revenue Market Share by Players (2019-2021E)
3.2 Global Anti–vascular Endothelial Growth Factor Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Anti–vascular Endothelial Growth Factor Therapy by Regions
4.1 Anti–vascular Endothelial Growth Factor Therapy Market Size by Regions (2016-2021)
4.2 Americas Anti–vascular Endothelial Growth Factor Therapy Market Size Growth (2016-2021)
4.3 APAC Anti–vascular Endothelial Growth Factor Therapy Market Size Growth (2016-2021)
4.4 Europe Anti–vascular Endothelial Growth Factor Therapy Market Size Growth (2016-2021)
4.5 Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size Growth (2016-2021)
5 Americas
5.1 Americas Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2016-2021)
5.2 Americas Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2016-2021)
5.3 Americas Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti–vascular Endothelial Growth Factor Therapy Market Size by Region (2016-2021)
6.2 APAC Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2016-2021)
6.3 APAC Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Anti–vascular Endothelial Growth Factor Therapy by Country (2016-2021)
7.2 Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2016-2021)
7.3 Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy by Region (2016-2021)
8.2 Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2016-2021)
8.3 Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Anti–vascular Endothelial Growth Factor Therapy Market Forecast
10.1 Global Anti–vascular Endothelial Growth Factor Therapy Forecast by Regions (2021-2026)
10.1.1 Global Anti–vascular Endothelial Growth Factor Therapy Forecast by Regions (2021-2026)
10.1.2 Americas Anti–vascular Endothelial Growth Factor Therapy Forecast
10.1.3 APAC Anti–vascular Endothelial Growth Factor Therapy Forecast
10.1.4 Europe Anti–vascular Endothelial Growth Factor Therapy Forecast
10.1.5 Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Forecast
10.2 Americas Anti–vascular Endothelial Growth Factor Therapy Forecast by Countries (2021-2026)
10.2.1 United States Anti–vascular Endothelial Growth Factor Therapy Market Forecast
10.2.2 Canada Anti–vascular Endothelial Growth Factor Therapy Market Forecast
10.2.3 Mexico Anti–vascular Endothelial Growth Factor Therapy Market Forecast
10.2.4 Brazil Anti–vascular Endothelial Growth Factor Therapy Market Forecast
10.3 APAC Anti–vascular Endothelial Growth Factor Therapy Forecast by Region (2021-2026)
10.3.1 China Anti–vascular Endothelial Growth Factor Therapy Market Forecast
10.3.2 Japan Anti–vascular Endothelial Growth Factor Therapy Market Forecast
10.3.3 Korea Anti–vascular Endothelial Growth Factor Therapy Market Forecast
10.3.4 Southeast Asia Anti–vascular Endothelial Growth Factor Therapy Market Forecast
10.3.5 India Anti–vascular Endothelial Growth Factor Therapy Market Forecast
10.3.6 Australia Anti–vascular Endothelial Growth Factor Therapy Market Forecast
10.4 Europe Anti–vascular Endothelial Growth Factor Therapy Forecast by Country (2021-2026)
10.4.1 Germany Anti–vascular Endothelial Growth Factor Therapy Market Forecast
10.4.2 France Anti–vascular Endothelial Growth Factor Therapy Market Forecast
10.4.3 UK Anti–vascular Endothelial Growth Factor Therapy Market Forecast
10.4.4 Italy Anti–vascular Endothelial Growth Factor Therapy Market Forecast
10.4.5 Russia Anti–vascular Endothelial Growth Factor Therapy Market Forecast
10.5 Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Forecast by Region (2021-2026)
10.5.1 Egypt Anti–vascular Endothelial Growth Factor Therapy Market Forecast
10.5.2 South Africa Anti–vascular Endothelial Growth Factor Therapy Market Forecast
10.5.3 Israel Anti–vascular Endothelial Growth Factor Therapy Market Forecast
10.5.4 Turkey Anti–vascular Endothelial Growth Factor Therapy Market Forecast
10.5.5 GCC Countries Anti–vascular Endothelial Growth Factor Therapy Market Forecast
10.6 Global Anti–vascular Endothelial Growth Factor Therapy Forecast by Type (2021-2026)
10.8 Global Anti–vascular Endothelial Growth Factor Therapy Forecast by Application (2021-2026)
11 Key Players Analysis
11.1 Regeneron Pharmaceuticals (Eylea)
11.1.1 Regeneron Pharmaceuticals (Eylea) Company Information
11.1.2 Regeneron Pharmaceuticals (Eylea) Anti–vascular Endothelial Growth Factor Therapy Product Offered
11.1.3 Regeneron Pharmaceuticals (Eylea) Anti–vascular Endothelial Growth Factor Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Regeneron Pharmaceuticals (Eylea) Main Business Overview
11.1.5 Regeneron Pharmaceuticals (Eylea) Latest Developments
11.2 Genentech
11.2.1 Genentech Company Information
11.2.2 Genentech Anti–vascular Endothelial Growth Factor Therapy Product Offered
11.2.3 Genentech Anti–vascular Endothelial Growth Factor Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Genentech Main Business Overview
11.2.5 Genentech Latest Developments
11.3 Kanghong Pharmaceutical
11.3.1 Kanghong Pharmaceutical Company Information
11.3.2 Kanghong Pharmaceutical Anti–vascular Endothelial Growth Factor Therapy Product Offered
11.3.3 Kanghong Pharmaceutical Anti–vascular Endothelial Growth Factor Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Kanghong Pharmaceutical Main Business Overview
11.3.5 Kanghong Pharmaceutical Latest Developments
...
12 Research Findings and Conclusion
List of Tables
Table 1. Antiâvascular Endothelial Growth Factor Therapy Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Extraction Injection
Table 3. Major Players of Precharge Injection
Table 4. Antiâvascular Endothelial Growth Factor Therapy Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 5. Global Antiâvascular Endothelial Growth Factor Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 6. Global Antiâvascular Endothelial Growth Factor Therapy Market Size Market Share by Type (2016-2021)
Table 7. Antiâvascular Endothelial Growth Factor Therapy Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 8. Global Antiâvascular Endothelial Growth Factor Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 9. Global Antiâvascular Endothelial Growth Factor Therapy Market Size Market Share by Application (2016-2021)
Table 10. Global Antiâvascular Endothelial Growth Factor Therapy Revenue by Players (2019-2021E) & ($ Millions)
Table 11. Global Antiâvascular Endothelial Growth Factor Therapy Revenue Market Share by Players (2019-2021E)
Table 12. Antiâvascular Endothelial Growth Factor Therapy Key Players Head office and Products Offered
Table 13. Antiâvascular Endothelial Growth Factor Therapy Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Antiâvascular Endothelial Growth Factor Therapy Market Size by Regions 2016-2021 & ($ Millions)
Table 17. Global Antiâvascular Endothelial Growth Factor Therapy Market Size Market Share by Regions 2016-2021
Table 18. Americas Antiâvascular Endothelial Growth Factor Therapy Market Size by Country (2016-2021) & ($ Millions)
Table 19. Americas Antiâvascular Endothelial Growth Factor Therapy Market Size Market Share by Country (2016-2021)
Table 20. Americas Antiâvascular Endothelial Growth Factor Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 21. Americas Antiâvascular Endothelial Growth Factor Therapy Market Size Market Share by Type (2016-2021)
Table 22. Americas Antiâvascular Endothelial Growth Factor Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 23. Americas Antiâvascular Endothelial Growth Factor Therapy Market Size Market Share by Application (2016-2021)
Table 24. APAC Antiâvascular Endothelial Growth Factor Therapy Market Size by Region (2016-2021) & ($ Millions)
Table 25. APAC Antiâvascular Endothelial Growth Factor Therapy Market Size Market Share by Region (2016-2021)
Table 26. APAC Antiâvascular Endothelial Growth Factor Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 27. APAC Antiâvascular Endothelial Growth Factor Therapy Market Size Market Share by Type (2016-2021)
Table 28. APAC Antiâvascular Endothelial Growth Factor Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 29. APAC Antiâvascular Endothelial Growth Factor Therapy Market Size Market Share by Application (2016-2021)
Table 30. Europe Antiâvascular Endothelial Growth Factor Therapy Market Size by Country (2016-2021) & ($ Millions)
Table 31. Europe Antiâvascular Endothelial Growth Factor Therapy Market Size Market Share by Country (2016-2021)
Table 32. Europe Antiâvascular Endothelial Growth Factor Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 33. Europe Antiâvascular Endothelial Growth Factor Therapy Market Size Market Share by Type (2016-2021)
Table 34. Europe Antiâvascular Endothelial Growth Factor Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 35. Europe Antiâvascular Endothelial Growth Factor Therapy Market Size Market Share by Application (2016-2021)
Table 36. Middle East & Africa Antiâvascular Endothelial Growth Factor Therapy Market Size by Region (2016-2021) & ($ Millions)
Table 37. Middle East & Africa Antiâvascular Endothelial Growth Factor Therapy Market Size Market Share by Region (2016-2021)
Table 38. Middle East & Africa Antiâvascular Endothelial Growth Factor Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 39. Middle East & Africa Antiâvascular Endothelial Growth Factor Therapy Market Size Market Share by Type (2016-2021)
Table 40. Middle East & Africa Antiâvascular Endothelial Growth Factor Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 41. Middle East & Africa Antiâvascular Endothelial Growth Factor Therapy Market Size Market Share by Application (2016-2021)
Table 42. Key and Potential Regions of Antiâvascular Endothelial Growth Factor Therapy
Table 43. Key Application and Potential Industries of Antiâvascular Endothelial Growth Factor Therapy
Table 44. Key Challenges of Antiâvascular Endothelial Growth Factor Therapy
Table 45. Key Trends of Antiâvascular Endothelial Growth Factor Therapy
Table 46. Global Antiâvascular Endothelial Growth Factor Therapy Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 47. Global Antiâvascular Endothelial Growth Factor Therapy Market Size Market Share Forecast by Regions (2021-2026)
Table 48. Global Antiâvascular Endothelial Growth Factor Therapy Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 49. Global Antiâvascular Endothelial Growth Factor Therapy Market Size Market Share Forecast by Type (2021-2026)
Table 50. Global Antiâvascular Endothelial Growth Factor Therapy Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 51. Global Antiâvascular Endothelial Growth Factor Therapy Market Size Market Share Forecast by Application (2021-2026)
Table 52. Regeneron Pharmaceuticals (Eylea) Details, Company Type, Antiâvascular Endothelial Growth Factor Therapy Area Served and Its Competitors
Table 53. Regeneron Pharmaceuticals (Eylea) Antiâvascular Endothelial Growth Factor Therapy Product Offered
Table 54. Regeneron Pharmaceuticals (Eylea) Antiâvascular Endothelial Growth Factor Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 55. Regeneron Pharmaceuticals (Eylea) Main Business
Table 56. Regeneron Pharmaceuticals (Eylea) Latest Developments
Table 57. Genentech Details, Company Type, Antiâvascular Endothelial Growth Factor Therapy Area Served and Its Competitors
Table 58. Genentech Antiâvascular Endothelial Growth Factor Therapy Product Offered
Table 59. Genentech Main Business
Table 60. Genentech Antiâvascular Endothelial Growth Factor Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 61. Genentech Latest Developments
Table 62. Kanghong Pharmaceutical Details, Company Type, Antiâvascular Endothelial Growth Factor Therapy Area Served and Its Competitors
Table 63. Kanghong Pharmaceutical Antiâvascular Endothelial Growth Factor Therapy Product Offered
Table 64. Kanghong Pharmaceutical Main Business
Table 65. Kanghong Pharmaceutical Antiâvascular Endothelial Growth Factor Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 66. Kanghong Pharmaceutical Latest Developments
List of Figures
Figure 1. Antiâvascular Endothelial Growth Factor Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Antiâvascular Endothelial Growth Factor Therapy Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Antiâvascular Endothelial Growth Factor Therapy Market Size Market Share by Type in 2020
Figure 7. Antiâvascular Endothelial Growth Factor Therapy in Macular Degeneration
Figure 8. Global Antiâvascular Endothelial Growth Factor Therapy Market: Macular Degeneration (2016-2021) & ($ Millions)
Figure 9. Antiâvascular Endothelial Growth Factor Therapy in Nacular Edema
Figure 10. Global Antiâvascular Endothelial Growth Factor Therapy Market: Nacular Edema (2016-2021) & ($ Millions)
Figure 11. Antiâvascular Endothelial Growth Factor Therapy in Uveitis
Figure 12. Global Antiâvascular Endothelial Growth Factor Therapy Market: Uveitis (2016-2021) & ($ Millions)
Figure 13. Antiâvascular Endothelial Growth Factor Therapy in Retinal Vein Occlusion
Figure 14. Global Antiâvascular Endothelial Growth Factor Therapy Market: Retinal Vein Occlusion (2016-2021) & ($ Millions)
Figure 15. Global Antiâvascular Endothelial Growth Factor Therapy Market Size Market Share by Application in 2020
Figure 16. Global Antiâvascular Endothelial Growth Factor Therapy Revenue Market Share by Player in 2020
Figure 17. Global Antiâvascular Endothelial Growth Factor Therapy Market Size Market Share by Regions (2016-2021)
Figure 18. Americas Antiâvascular Endothelial Growth Factor Therapy Market Size 2016-2021 ($ Millions)
Figure 19. APAC Antiâvascular Endothelial Growth Factor Therapy Market Size 2016-2021 ($ Millions)
Figure 20. Europe Antiâvascular Endothelial Growth Factor Therapy Market Size 2016-2021 ($ Millions)
Figure 21. Middle East & Africa Antiâvascular Endothelial Growth Factor Therapy Market Size 2016-2021 ($ Millions)
Figure 22. Americas Antiâvascular Endothelial Growth Factor Therapy Market Size Market Share by Country in 2020
Figure 23. Americas Antiâvascular Endothelial Growth Factor Therapy Market Size Market Share by Type in 2020
Figure 24. Americas Antiâvascular Endothelial Growth Factor Therapy Market Size Market Share by Application in 2020
Figure 25. United States Antiâvascular Endothelial Growth Factor Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 26. Canada Antiâvascular Endothelial Growth Factor Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 27. Mexico Antiâvascular Endothelial Growth Factor Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 28. APAC Antiâvascular Endothelial Growth Factor Therapy Market Size Market Share by Regions in 2020
Figure 29. APAC Antiâvascular Endothelial Growth Factor Therapy Market Size Market Share by Type in 2020
Figure 30. APAC Antiâvascular Endothelial Growth Factor Therapy Market Size Market Share by Application in 2020
Figure 31. China Antiâvascular Endothelial Growth Factor Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 32. Japan Antiâvascular Endothelial Growth Factor Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 33. Korea Antiâvascular Endothelial Growth Factor Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 34. Southeast Asia Antiâvascular Endothelial Growth Factor Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 35. India Antiâvascular Endothelial Growth Factor Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 36. Australia Antiâvascular Endothelial Growth Factor Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 37. Europe Antiâvascular Endothelial Growth Factor Therapy Market Size Market Share by Country in 2020
Figure 38. Europe Antiâvascular Endothelial Growth Factor Therapy Market Size Market Share by Type in 2020
Figure 39. Europe Antiâvascular Endothelial Growth Factor Therapy Market Size Market Share by Application in 2020
Figure 40. Germany Antiâvascular Endothelial Growth Factor Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 41. France Antiâvascular Endothelial Growth Factor Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 42. UK Antiâvascular Endothelial Growth Factor Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 43. Italy Antiâvascular Endothelial Growth Factor Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 44. Russia Antiâvascular Endothelial Growth Factor Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 45. Middle East & Africa Antiâvascular Endothelial Growth Factor Therapy Market Size Market Share by Region in 2020
Figure 46. Middle East & Africa Antiâvascular Endothelial Growth Factor Therapy Market Size Market Share by Type in 2020
Figure 47. Middle East & Africa Antiâvascular Endothelial Growth Factor Therapy Market Size Market Share by Application in 2020
Figure 48. Egypt Antiâvascular Endothelial Growth Factor Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 49. South Africa Antiâvascular Endothelial Growth Factor Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 50. Israel Antiâvascular Endothelial Growth Factor Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 51. Turkey Antiâvascular Endothelial Growth Factor Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 52. GCC Country Antiâvascular Endothelial Growth Factor Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 53. Americas Antiâvascular Endothelial Growth Factor Therapy Market Size 2021-2026 ($ Millions)
Figure 54. APAC Antiâvascular Endothelial Growth Factor Therapy Market Size 2021-2026 ($ Millions)
Figure 55. Europe Antiâvascular Endothelial Growth Factor Therapy Market Size 2021-2026 ($ Millions)
Figure 56. Middle East & Africa Antiâvascular Endothelial Growth Factor Therapy Market Size 2021-2026 ($ Millions)
Figure 57. United States Antiâvascular Endothelial Growth Factor Therapy Market Size 2021-2026 ($ Millions)
Figure 58. Canada Antiâvascular Endothelial Growth Factor Therapy Market Size 2021-2026 ($ Millions)
Figure 59. Mexico Antiâvascular Endothelial Growth Factor Therapy Market Size 2021-2026 ($ Millions)
Figure 60. Brazil Antiâvascular Endothelial Growth Factor Therapy Market Size 2021-2026 ($ Millions)
Figure 61. China Antiâvascular Endothelial Growth Factor Therapy Market Size 2021-2026 ($ Millions)
Figure 62. Japan Antiâvascular Endothelial Growth Factor Therapy Market Size 2021-2026 ($ Millions)
Figure 63. Korea Antiâvascular Endothelial Growth Factor Therapy Market Size 2021-2026 ($ Millions)
Figure 64. Southeast Asia Antiâvascular Endothelial Growth Factor Therapy Market Size 2021-2026 ($ Millions)
Figure 65. India Antiâvascular Endothelial Growth Factor Therapy Market Size 2021-2026 ($ Millions)
Figure 66. Australia Antiâvascular Endothelial Growth Factor Therapy Market Size 2021-2026 ($ Millions)
Figure 67. Germany Antiâvascular Endothelial Growth Factor Therapy Market Size 2021-2026 ($ Millions)
Figure 68. France Antiâvascular Endothelial Growth Factor Therapy Market Size 2021-2026 ($ Millions)
Figure 69. UK Antiâvascular Endothelial Growth Factor Therapy Market Size 2021-2026 ($ Millions)
Figure 70. Italy Antiâvascular Endothelial Growth Factor Therapy Market Size 2021-2026 ($ Millions)
Figure 71. Russia Antiâvascular Endothelial Growth Factor Therapy Market Size 2021-2026 ($ Millions)
Figure 72. Spain Antiâvascular Endothelial Growth Factor Therapy Market Size 2021-2026 ($ Millions)
Figure 73. Egypt Antiâvascular Endothelial Growth Factor Therapy Market Size 2021-2026 ($ Millions)
Figure 74. South Africa Antiâvascular Endothelial Growth Factor Therapy Market Size 2021-2026 ($ Millions)
Figure 75. Israel Antiâvascular Endothelial Growth Factor Therapy Market Size 2021-2026 ($ Millions)
Figure 76. Turkey Antiâvascular Endothelial Growth Factor Therapy Market Size 2021-2026 ($ Millions)
Figure 77. GCC Country Antiâvascular Endothelial Growth Factor Therapy Market Size 2021-2026 ($ Millions)